Overview
Observational, retrospective data collection and prospective IgG analysis, and multicenter study.
The main objective of the study is th description of the characteristics and evolution of patients with lung cancer who have acquired COVID-19 infection.
For the identification of patients who contract COVID-19 infection, the IgG+ blood test by ELISA method will be used.
Eligibility
Inclusion Criteria:
- Patients diagnosed with lung cancer at any stage of the disease
- Age 18
- Patients who have signed the informed consent for this study
Exclusion Criteria:
- Patients who have not signed or do not wish to sign the informed consent for this study